BioSpace News Archive

Evotec AG announced today that its management will be presenting and attending the following upcoming conferences:

Karyopharm Therapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to selinexor, the Company’s first in class, oral SINE compound, for the treatment of patients with diffuse large B-cell lymphoma (DLBCL) who have received at least two prior therapies and are not eligible for high dose chemotherapy with stem cell rescue or CAR-T therapy.

GE Healthcare partners with Wego to provide locally manufactured single-use consumables for bioprocessing in China

TxCell SA today reports its financial information for the 3rd quarter of 2018.

The interval at which an individual undergoes a repeat colonoscopy because of previous pre-cancerous polyps -- a practice known as “surveillance” -- should be tailored to the individual and not simply be determined by the results of prior colonoscopies, according to Regenstrief Institute research scientist Thomas F. Imperiale, M.D.

Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow

Retrophin, Inc. today announced that Stephen Aselage, chief executive officer, will present at the Jefferies 2018 London Healthcare Conference in London, UK on Wednesday, November 14, 2018 at 4:40 p.m. GMT (11:40 a.m. ET).

Development, licence and supply agreement for treatment of migraine in US market

Net sales amounted to SEK 1,421 million (1,200), an increase of 18%

The quality of medical certificates written by students of medicine was better when they were taught by using the flipped classroom approach instead of traditional lecturing.